Turkey Aims To Save $175m Via ‘Base Price’ Reimbursement
This article was originally published in The Pink Sheet Daily
Executive Summary
Turkey has launched a “base price” reimbursement payment policy for key generics covering cardiovascular, respiratory and stomach ailments among others that aims to save the government TL 400 million ($175 million) annually.